Showing results (331-340 of 508) with videos related to

Sort By:
Pageof 51
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE studyMichal L Melamed, Joseph A Eustace, Laura C Plantinga, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities StudyAdrienne Tin, Morgan E Grams, Nisa M Maruthur, et al.
Kidney360|April 4, 2022
Frailty, Age, and Postdialysis Recovery Time in a Population New to HemodialysisJessica Fitzpatrick, Stephen M Sozio, Bernard G Jaar, et al.
Diabetes Care|December 20, 2012
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patientsTariq Shafi, Stephen M Sozio, Laura C Plantinga, et al.
Molecular Biology Reports|June 1, 2024
The scaffold protein disabled 2 (DAB2) and its role in tumor development and progressionDisha V Pandya, Rajsi V Parikh, Ruhanahmed M Gena, et al.
Life Sciences|November 2, 2023
Anti-CD4 antibody and dendrimeric peptide based targeted nano-liposomal dual drug formulation for the treatment of HIV infectionSadhana P Mutalik, Shraddha Y Gaikwad, Gasper Fernandes, et al.
Journal of Infection in Developing Countries|December 16, 2011
Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in IndiaHitt J Sharma, Vasant S Padbidri, Subhash V Kapre, et al.
AIDS (London, England)|March 1, 1993
Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from ThailandC P Pau, S Lee-Thomas, W Auwanit, et al.
Kidney International Reports|February 22, 2021
<i>APOL1</i> Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis PatientsTeresa K Chen, Jessica Fitzpatrick, Cheryl A Winkler, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 3, 2019
Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) studyAli I Gardezi, Muhammad S Karim, Joel E Rosenberg, et al.
Pageof 51